Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Baxdela meets the primary endpoints in confirmatory phase III study

May 17, 2016

Tetraphase receives FDA guidance on eravacycline program

May 13, 2016

Vaccitech launched from Oxford Sciences

May 13, 2016

CIADM begins advanced development of anthrax vaccine

May 12, 2016

Novel pGX2303 vaccine provides full protection against RSV in animal model

May 12, 2016

Phase I/II results for novel maternal trivalent GBS vaccine

May 12, 2016

US Phytotherapy conducting preclinical studies of PROACT-Z for Zika infection

May 11, 2016

Janssen plans phase IIb study of AL-335, odalasvir and simeprevir combinations for chronic HCV

May 11, 2016

VBI Vaccines and SciVac Therapeutics complete merger

May 10, 2016

CSIR discloses antimalaria compounds

May 10, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...